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Abstract
Mutations in sorting nexin 10 (Snx10) have recently been found to account for roughly 4%
of all human malignant osteopetrosis, some of them fatal. To study the disease pathogene-
sis, we investigated the expression of Snx10 and created mouse models in which Snx10
was knocked down globally or knocked out in osteoclasts. Endocytosis is severely defective
in Snx10-deficent osteoclasts, as is extracellular acidification, ruffled border formation, and
bone resorption. We also discovered that Snx10 is highly expressed in stomach epithelium,
with mutations leading to high stomach pH and low calcium solubilization. Global Snx10-de-
ficiency in mice results in a combined phenotype: osteopetrosis (due to osteoclast defect)
and rickets (due to high stomach pH and low calcium availability, resulting in impaired bone
mineralization). Osteopetrorickets, the paradoxical association of insufficient mineralization
in the context of a positive total body calcium balance, is thought to occur due to the inability
of the osteoclasts to maintain normal calcium–phosphorus homeostasis. However, osteo-
clast-specific Snx10 knockout had no effect on calcium balance, and therefore led to severe
osteopetrosiswithout rickets. Moreover, supplementation with calcium gluconate rescued
mice from the rachitic phenotype and dramatically extended life span in global Snx10-defi-
cient mice, suggesting that this may be a life-saving component of the clinical approach to
Snx10-dependent human osteopetrosis that has previously gone unrecognized. We con-
clude that tissue-specific effects of Snx10 mutation need to be considered in clinical ap-
proaches to this disease entity. Reliance solely on hematopoietic stem cell transplantation
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can leave hypocalcemia uncorrected with sometimes fatal consequences. These studies
established an essential role for Snx10 in bone homeostasis and underscore the impor-
tance of gastric acidification in calcium uptake.
Author Summary
We found that Snx10, a molecule expressed in osteoclasts, was also expressed in the stom-
ach. Studies in tissue specific or global knock-down mice showed that Snx10 deficiency re-
sulted in a phenotype that was a consequence of deficiencies in both osteoclasts and gastric
zymogenic cells. Our studies add to a growing list of genes, including atp6i (Tcirg 1), whose
expression is required both in bone and stomach to maintain normal gastric acidification
and calcium absorption. This work provides additional insight into the mechanisms govern-
ing the regulation of bone accrual by the gastrointestinal tract. Because osteopetrorickets has
not been described clinically in Snx10-related osteopetrosis, these findings highlight the im-
portance of considering impaired acidification in both stomach and bone in osteopetrotic
patients with mutations in SNX10 and other genes with similar patterns of expression and
activities. Because defects in gastric differentiation and/or gastric acidification may cause or
contribute to hypocalcemia, bone insufficiency, and early death, our results suggest that die-
tary calcium supplementation could be a life-saving intervention in these patients.
Introduction
The function of the bone-resorbing osteoclast is highly dependent on vesicular trafficking path-
ways [1]. Endocytosis and intracellular trafficking of the endocytosed material are required for
many osteoclast functions, including creation of the ruffled border; secretion of ions and prote-
ases to digest bone; to engulf the digested material; to move it across the cell by transcytosis;
and to secrete the products of digestion [2,3]. Disruption (genetic or pharmacological) of osteo-
clastic vesicle transport abolishes resorptive activity [1]. For example, osteoclasts from human
patients and from rats deficient in Plekhm1, a protein with a critical function in vesicular trans-
port in osteoclasts, develop osteopetrosis and have osteoclasts with secretory defects and which
lack ruffled borders [4].
Members of the sorting nexin (Snx) family of proteins are known to mediate endosomal
sorting, endocytosis, recycling of membrane proteins, and trafficking between various endo-
somes and Golgi apparatus [5]. The Snx family consists of a diverse group of cytoplasmic and
membrane-associated proteins that are unified by a common phospholipid-binding motif, the
PX domain. They participate in protein sorting and membrane trafficking by means of pro-
tein-protein complexes and protein-lipid interactions. [5]. Overexpression of one Snx family
member, Snx10, induced giant vacuoles in mammalian cells [6].
During investigations of genes differentially expressed during RANKL-induced osteoclast
differentiation, we found Snx10 to be very strongly upregulated both in vitro and in vivo [7].
Immunohistochemical analysis of mouse embryo sections showed expression in long bone, cal-
variae, and developing teeth. Snx10 was expressed in cells that also express tartrate-resistant
acid phosphatase (TRAP), demonstrating osteoclastic localization [7]. Snx10 silencing inhib-
ited formation of resorption pits on hydroxyapatite and also TRAP secretion [7]. Taken togeth-
er, these results indicate that Snx10 is expressed in osteoclasts and is required for osteoclast
activity in vitro.
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In 2012, SNX10mutations were discovered in patients with infantile autosomal recessive
osteopetrosis. One was a point mutation that caused a single amino acid change in a highly
conserved residue, R51Q, [8] and one introduced a premature stop codon [9]. Osteoclasts from
these patients showed reduced resorptive capacity and altered endosomal pathways [8]. In
2013, nine novel mutations in SNX10 were then described in 14 autosomal recessive osteope-
trosis (ARO) patients, and together, SNX10mutations are now known to accounting for about
4% of known ARO cases, roughly the same proportion as mutations in the RANK-RANKL
pathway or inOSTM1 [10]. Most patients with SNX10mutations benefited from hematopoietic
stem cell transplants (HSCT). However, some patients exhibited symptoms consistent with
osteopetrorickets and did not experience improvement after HSCT, which suggests that bone
may not be the only site of expression [10].
Several molecules in the acid producing system are expressed in both bone and stomach cell
types, including Atp6i, Clc-7 and Ae2. ATP6i [11] and Ae2 [12–14] loss-of-function mutants
develop osteopetrorickets due to simultaneous acidification defects leading to osteoclast dys-
function and impaired calcium absorption. Osteopetrorickets has been described in both hu-
mans and in mice and it is often fatal in infants. It manifests as the seemingly paradoxical
combination of dense, sclerotic bones, but with defective mineralization of hypertrophic carti-
lage and of osteoid, often in the presence of elevated parathyroid hormone, alkaline phospha-
tase, and decreased 1,25-dihydroxyvitamin D levels [15,16]. While rickets was once considered
a rare complication of osteopetrosis, it has been suggested that osteopetrorickets is more com-
mon than previously thought [17–19].
Given its critical role in osteoclast function [7], it seemed likely that Snx10 may also regulate
acid production in the stomach. To study the role of Snx10 in bone homeostasis in vivo we gen-
erated strains of mice that carry either a global knockdown of Snx10 or an osteoclast-specific
knockout. We report here that Snx10 is highly expressed, not only in osteoclasts, but also in
gastric epithelium, leading to osteoclastic and gastric acidification defects, similar to the
Tcirg1-deficient oc/oc mice [11]. We also show that osteoclast-specific knockout of Snx10 led
to severe osteopetrosis, but without rickets, and that dietary calcium supplementation rescued
mice with a global knockdown of Snx10 from the rachitic phenotype and prevented juvenile le-
thality, indicating that this simple remedy should always be considered clinically.
Results
Consequences of global Snx10 deficiency in vivo: osteopetrosis and
rickets
In order to study the role of Snx10 in osteoclast function and bone homeostasis in vivo we gen-
erated mice from KOMP gene-trapped ES cells (PG00216_Z_2_C06, S1A Fig.). This targeting
construct places a selection cassette and several recombination sites within intron 3, flanks
exons 4 and 5 with loxP sites, and disrupts transcription. PCR genotyping (S1B Fig.) and
mRNA levels (S1C Fig.) validated correct insertion and revealed an 86% reduction in Snx10
levels in bones from the resulting, homozygous mice compared to wildtype littermates (relative
expression = 0.14 vs. 1.03, n = 4 per group, p<0.05, S1C Fig.). We have designated these mice
Snx10Neo-f/Neo-f (see EXPERIMENTAL PROCEDURES) and we hereafter refer to them as
“Snx10 KD” for Snx10 knockdown to reflect the global insufficiency of Snx10 expression.
Snx10 KD mice die between 3 and 4 weeks post-partum. By 14 days of age Snx10 KD mice
exhibited severe growth retardation compared to WT or heterozygous controls (Fig. 1A), with
failed tooth eruption (compare Fig. 1B and 1C). The overall skeletal development was im-
paired, with higher radio-density in the 3-week-old Snx10 KD mice (Fig. 1E, 1G and 1I) com-
pared with the wild-type mice (Fig. 1D, 1F and 1H). Further skeletal examination of 3 week-
Control of Bone and Calcium Homeostasis by Snx10
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Fig 1. Morphological and radiographic examination of Snx10 KDmice. A) 2-week-old Snx10 KDmice are growth retarded. 2-week-old Snx10 KDmice
(C and E) have a tooth eruption defect compared to their WT littermates (B and D). The white arrows (D and E) demonstrate the presence of tooth buds that
failed to erupt in the KDmice. Radiographic images demonstrate that 3-week-old Snx10 KDmice (G and I) have bones that lack marrow cavities. Compare
the femur (white arrow) and pelvis (black arrow) with WT (F and H) mice. The metaphyseal cupping in the Snx10 KD femur and tibia (I) are consistent
with rickets.
doi:10.1371/journal.pgen.1005057.g001
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old mice by micro-CT (Fig. 2) confirmed that the long bones of Snx10 KD mice were filled
with unresorbed trabecular bone and lacked marrow spaces, consistent with a severely osteope-
trotic phenotype. Micro-CT analysis of the femur, skull, and mandible performed in Snx10 KD
mice (n = 4) and WT littermates (n = 3) confirmed the osteopetrotic phenotype. In fact, Snx10
KD mice had significantly higher BV/TV (0.31 +/− 0.052 vs 0.070 +/− 0.004, P = 0.0006),
higher trabecular number (15.17 +/− 2.92 1/mm vs 2.29 +/− 0.004 1/mm, P = 0.0007) and sig-
nificantly reduced trabecular spacing (0.061 +/− 0.009 mm vs 0.391 +/− 0.042mm, P =
1.97535E-05) thanWT. Trabecular thickness values, on the other hand, were not different
(0.032 +/− 0.002 mm for the Snx10 KD, 0.031 +/− 0.004 mm for the WT, p = 0.793). The abun-
dance of trabecular bone suggests that the observed phenotype is mainly the result of an osteo-
clast defect. In addition, all examined Snx10 KD bones exhibited a thinned or absent cortex,
producing a dramatic “moth-eaten” appearance (Fig. 2A, 2B, and 2C). Finally, analysis both by
radiograph and by micro-CT of transverse sections of long bones (femur, tibia, humerus) re-
vealed an inner ring of cortex-like (denser) bone within the trabecular bone (shown in the
femur, Fig. 2E and 2G). This is reminiscent of the classic “bone-in-bone” or "bone within bone"
appearance, a typical radiologic finding in osteopetrosis, usually reserved for the vertebral col-
umn [15,17,20–22]. Radiographs also revealed metaphyseal fraying and cupping (Fig. 1I), in-
dicative of rickets superimposed on osteopetrosis, or “osteopetrorickets.” To confirm this, we
compared Snx10 KD mice with Tcirg1 (Atp6i) KO mice [23], which display both hypocalcemia
and osteopetrorickets [11]. Radiograph and micro-CT analysis (S2 Fig.) demonstrated that that
the Tcirg1 KOmice were strikingly similar to the Snx10 KD mice by radiograph and micro-
CT, with lack of cortical bone, metaphyseal cupping and fraying, and non-mineralized con-
dyles and articulations, all characteristic of rickets. Moreover, biochemical investigations
showed hypocalcaemia and high PTH together with low levels of serum 25-hydroxy vitamin D
(see below). Based on our own findings and reports on mice and humans with TCIRG1muta-
tions, we conclude that the Snx10 KD mice have a phenotype of osteopetrosis with super-im-
posed rickets: osteopetrorickets [17,24].
Analysis of bone mineral density by DXA demonstrated that BMD is reduced*14% in
Snx10 KD mice compared to WT mice (0.0337 +/− 0.002 g/cm2 vs. 0.0393 +/− 0.003 g/cm2, re-
spectively. n = 6 per group, P = 0.02). Furthermore, BMC is reduced 43% (0.114 +/− 0.043 g vs.
0.199 +/− 0.034 g, Snx10 KD and WT respectively, P = 0.006). The greater reduction in BMC is
likely a reflection of both reduced BMD and the small size of the Snx10 KD mice
These observations were further confirmed by histological analysis of femora from 3-week-
old mice. Low magnification images (Fig. 3A and 3B), demonstrated: 1) a marrow cavity almost
completely filled with unresorbed, poorly mineralized cartilage, and 2) thinning of cortical
bone (black arrowheads) in the Snx10 KD mice. High magnification images of von Kossa/van
Gieson stained undecalcified longitudinal sections of femora fromWT and Snx10 KD mice
confirmed the presence of numerous trabeculae within the bone marrow space of Snx10 KD
bones (Fig. 3D). Interestingly, the van Gieson counterstain also revealed the presence of non-
mineralized osteoid on the surface of the trabeculae (Fig. 3D). Histomorphometry performed
on longitudinal femoral sections confirmed a significant increase in growth plate thickness
(GpTh,) in Snx10 KDmice compared toWTmice (0.286 +/− 0.062 mm and 0.175 +/− 0.010 mm,
respectively, P = 0.04, n = 3 per group, S2 Table). We also detected a significant increase in Os-
teoid volume per Bone volume (OV/BV, %) in Snx10 KD mice (26.97 +/− 8.19% and 2.88 +/−
1.63%, respectively, P = 0.01) and in Bone volume / Tissue volume (BV/TV, %) (20.69 +/− 2.15%
for the WT and 28.11 +/− 0.98% for the Snx10 KD, P = 0.02, S2 Table). Histomorphometry
performed on sections from lumbar vertebral bodies (S4 Table) and from skull base/floor
bones (S5 Table) show similar results. Put together, these results confirm a combined
Control of Bone and Calcium Homeostasis by Snx10
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phenotype in Snx10 KD mice characterized by both a bone mineralization defect (rickets) and
osteopetrosis due to defective osteoclast resorption.
We performed mechanical testing of tibial diaphyses (three-point-bending) to obtain the
following parameters: maximal load, stiffness, energy to failure, and maximal displacement,
which together provide an accurate picture of the biomechanical status of bone [25]. We found
that the tibiae of Snx10 KD mice have significantly lower maximal load (P = 0.0025), stiffness
(P = 0.001), energy to failure (P = 0.027), and greater maximal displacement (P = 0.05) com-
pared to WT (n = 6, S1 Table). Therefore, compared to WT, the long bones of Snx10 KD mice
are weaker, less mineralized, and easier to deform in response to mechanical stress. It should
be noted that all the mentioned values (maximal load, stiffness, energy to failure and displace-
ment) are dependent on bone size. Therefore the values obtained for bones from Snx10 global
Fig 2. Micro CT analysis of Snx10 KDmice. (A, top) Surface images of the femur demonstrate a deficiency
of mineralized cortical bone. Longitudinal mid-plane images of the femur (A, bottom) show a marrow cavity
filled with unresorbed bone in Snx10 KDmice. Other examined bones: head, (B) and mandible (C) also were
deficient in cortical bone, producing a “moth-eaten” appearance. Cross sectional micro CT images of femur
(D, E, F and G) reveal the presence of an inner ring of cortex-like (i.e., denser) bone in Snx10 KD bones (E
and G).
doi:10.1371/journal.pgen.1005057.g002
Fig 3. Histology of bone fromWT and Snx10 KDmice. Lowmagnification of Von Kossa/van Gieson
staining (A and B) of femur longitudinal sections from 3 week-old mice demonstrate endosteum filled with
unresorbed cartilage (purple stained trabecular cores) and thin cortical bone (black arrowheads) in Snx10 KD
mice (B). Higher magnification (C and D) reveals non-mineralized osteoid (pink-stained surface, indicated
with asterisks), covering the mineralized trabeculae (black) from Snx10 KD bones (D) Bar = 0.05 mm
doi:10.1371/journal.pgen.1005057.g003
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deficient mice (Snx10 KD) reflect the fact that they have different material properties and that
they are smaller. These results are consistent with rickets, which leads to softening and weaken-
ing of the bones (osteomalacia) [24], whereas osteopetrosis alone results in hard, brittle bones
due to the persistence of woven bone [22,26].
Taken together, these results show that Snx10 is essential for bone homeostasis and to main-
tain normal biomechanical properties of long bones.
Snx10 deficiency inhibits osteoclast activity
An osteopetrotic phenotype can be the result of absent osteoclasts (e.g., RANKL knockout),
which indicates a defect in osteoclast differentiation. Osteopetrosis can also result from im-
paired osteoclast function (e.g., c-Src knockout [27]). Histological analysis showed that bones
from Snx10 KD mice have TRAP-positive osteoclasts (S2A Fig.), which suggests that Snx10 de-
ficiency affects osteoclast function.
Due to the lack of marrow in Snx10 KD mice, we used splenocytes as a source of osteoclast
precursors fromWT and Snx10 KD mice for ex vivo differentiation experiments. Snx10 KD
splenocytes gave rise to multinucleated osteoclasts, confirming that Snx10 deficiency does not
inhibit osteoclast formation (S2C Fig.). In pit formation assays we found that, although the
Snx10-deficient cells gave rise to TRAP-positive multinucleated osteoclasts, the total area re-
sorbed by Snx10 KD osteoclasts was reduced by 94% (S2D Fig., top panel) (3.99 +/− 1.41 mm2
for the WT, 0.26 +/−0.15 mm2 for the Snx10 KD, n = 6, P = 0.04), in agreement with our
knockdown results [7]. Finally, infection of Snx10 KD splenocytes with a retrovirus expressing
Snx10 reintroduced Snx10 expression (S2D Fig., bottom panel) and corrected the pit formation
defect (2.25 +/− 0.62 mm2 n = 6, p = 0.008), confirming that Snx10 deficiency is responsible for
the resorption defect (S2D Fig., top and middle panels).
To determine the effect of Snx10 deficiency on bone turnover, we assessed levels of serum
markers for bone formation (osteocalcin) and resorption (collagen I C-telopeptide; CTX). We
found no significant differences in osteocalcin (18.35 +/− 1.81 ng/ml in the WT and 15.09 +/−
0.18 ng/ml in the Snx10 KD, n = 6, P = 0.127), suggesting that the bone phenotype observed in
Snx10 KD is not primarily a bone formation defect. In contrast, serum CTX levels were signifi-
cantly elevated in Snx10 KDmice compared to WT mice (88.56 +/− 5.67 ng/ml in the WT and
220.09 +/− 16.77 ng/ml in Snx10 KD, n = 6, P = 0.0002). This seemingly contradictory finding
is consistent with reports in other osteopetrosis models [28–30], and may be due to the very
large bone area resulting in a much larger total number of osteoclasts in the Snx10 KD mice
(see Discussion).
Impaired gastric acidification with subsequent hypocalcemia leads to
osteopetrorickets in Snx10 KDmice
Morphological examination of stomachs (n = 6) showed that Snx10 KD mice have an abnor-
mal digestive tract, with stomachs prone to hemorrhagic necrosis (Fig. 4A), suggesting that
Snx10 deficiency may result in a functionally impaired digestive system. Since Snx10 is re-
quired for extracellular acidification in osteoclasts, we hypothesized that it might also be re-
quired for gastric acid production and subsequent normal intestinal calcium absorption. To
test this, we first examined Snx10 expression by qPCR analysis and found it to be expressed in
the stomach and bone, but not in heart, muscle or intestine (Fig. 4B, left panel). In the stomach,
expression was restricted to the oxyntic mucosa of the body/corpus (Fig. 4B, right panel), the
region producing gastric acid. Expression of Snx10 mRNA in the stomach of Snx10 KD mice is
reduced by 78% compared to WT. This is a similar reduction to that in bone (S1C Fig.). Immu-
nofluorescence of stomach sections confirmed that Snx10 is normally present predominately
Control of Bone and Calcium Homeostasis by Snx10
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in the intracellular secretory granules of zymogenic chief (ZC) cells (Fig. 4C, WT). Immunoflu-
orescence shows that Snx10 antibody labels ZC cells at the base of the gastric units only in WT
mice (S4A Fig., bottom). ZC in WT are large cells containing apical cytoplasm filled with secre-
tory granules which show intense labeling for the marker, GIS, whereas in Snx10 KD mice, ZCs
Fig 4. Snx10 is expressed in the stomach and is required for gastric acid production and calcium homeostasis. A) Representative stomachs from 3-
week old Snx10 KDmice (n = 6) andWT littermates (n = 6). Snx10 KDmice have abnormal stomachs. B) mRNA expression of Snx10 (left panel) is mainly
observed in stomach and bone. Within the stomach (right panel) expression of Snx10 mRNA is mainly observed in the body/corpus of the stomach ("Body"),
where levels are comparable to the femur; expression is lower in the antrum and the non-glandular forestomach. C) Immunofluorescence images from
stomach sections stained for pepsinogen (a zymogenic cell marker), Snx10 and GSII (a mucous neck cell marker) shows Snx10-specific staining (green) in
zymogenic cells. D) Sections of the body of the stomach stained for the parietal cell marker VEGF-B (red), show that Snx10-deficient parietal cells are
smaller, have abnormal nuclear morphology, increased nuclear to cytoplasmic ratio, and an abnormal cellular distribution of VEGF-B. E) Gastric pH is
significantly elevated in Snx10 KDmice indicating that Snx10 is required for gastric acid production (* P<0.05). F) Serum calcium is reduced in Snx10 KD
mice, indicating that Snx10 is required for calcium homeostasis (*P<0.05). G) Serum parathyroid hormone (PTH) is significantly elevated in Snx10 KD (* P =
0.001). H) 1,25-dihydroxyvitamin D levels are reduced in Snx10 KDmice (* P = 0.01).
doi:10.1371/journal.pgen.1005057.g004
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are smaller and have sparser, more punctate granules with weak GIS staining (S4A Fig.). This
resembles other mouse models with defects in secretory granule maintenance/formation, such
as theMist1-/- mouse [31,32]. GSII labels mucous neck cells, which are interspersed between
parietal cells and define the mid/neck region of each gastric unit. Their abundance and location
in Snx10 KD mice are not distinguishable fromWT. H&E staining (S4B Fig.) suggests a small
size and high nuclear:cytoplasmic ratio of parietal cells in Snx10 KD mice. The ZCs, lacking
their abundant apical granules, are also smaller, and there are increased parietal cells in the
base (ZC) zone (S4B Fig., bottom, black arrowheads). Stomach sections were also stained for
the parietal cell marker VEGF-B [33]. We confirmed that, compared to their WT counterparts,
Snx10-deficient parietal cells are smaller and have an increased nuclear to cytoplasmic ratio
(Fig. 4D). Also, VEGF-B is focused in a ring-like cytoplasmic pattern in Snx10-deficient parie-
tal cells, whereas it is broadly distributed baso-laterally in WT cells, suggesting a defect in cellu-
lar protein trafficking.
To study possible functional consequences of Snx10 deficiency in the stomach, we measured
gastric pH in WT and Snx10 KD stomachs. We detected a significant increase in stomach pH
of Snx10 KD mice compared to WT mice (Fig. 4E, 4.62 +/− 0.43 vs. 2.50 +/−0.32, respectively,
n = 5 per group, P<0.001). Taken together, these findings demonstrate that Snx10 is expressed
in the stomach and its expression is required for stomach acidification. Because impaired stom-
ach acidification reduces calcium absorption by the intestine, we investigated whether Snx10
was required for maintaining calcium homeostasis, which could explain the rachitic aspects of
the phenotype.
Assessment of serum calcium confirmed that Snx10 KD mice are severely hypocalcemic
compared to their WT littermates (KO 6.40 +/− 2.46 mg/dl vs WT 10.21 +/− 1.81 mg/dl, n = 6
per group, P = 0.01, Fig. 4F). They also had higher serum parathyroid hormone PTH (0.748 +/−
0.127 ng/ml, Fig. 4G) compared to the WT (0.142 +/− 0.023 ng/m, n = 3 per group, P = 0.001)
and lower 1,25-dihydroxyvitamin D levels (0.071 +/− 0.014 nmol, Fig. 4H), compared to WT
(0.129 +/− 0.017 nmol, n = 3 per group, P = 0.01); both typical manifestations of osteopetror-
ickets [17–19]. Taken together, these results suggest that the rachitic features of Snx10 KD are
due to hypocalcemia caused by the acidification defect in the stomach.
To confirm this, we performed calcium supplementation to rescue mice from the Snx10 KD
rachitic phenotype. The diet included 2% calcium gluconate and 2,000 IU kg-1 vitamin D as de-
scribed [11]. Due to the tissue damage seen in the stomachs of Snx10 KD mice we sought to
improve calcium uptake by also giving sub-cutaneous injections of 2% calcium gluconate dilut-
ed in saline (50μl per day). Calcium supplementation was initiated at 14 days after birth and
continued for 10 days. In a parallel survival experiment, mice (n = 5) were treated at 14 days
after birth for 16 weeks. Calcium supplementation of Snx10 KD mice prevented the premature
death seen at 3–4 weeks in the untreated mice. All mice receiving supplementation survived
for the duration of the survival experiment. Treatment restored normocalcemia (10.52 +/−
0.43 mg/dl for treatment group vs. 10.70 +/− 0.46 mg/dl for the WT group, n = 6, P = 0.661)
(Fig. 5A, left), bone mineral density (n = 6, P = 0.006) and bone mineral content (n = 6, P =
0.001). Radiographic analysis of femora demonstrated mineralization of the condyles and pa-
tellae in the calcium supplementation group (Fig. 5B, Snx10 KD+Ca panel) in contrast to the
untreated Snx10 KD mice (Fig. 1I). Also, mutant mice receiving calcium supplementation
lacked frayed or cupped metaphyseal plates (compare 1I and 5B), consistent with rescue from
rickets. These results were further confirmed by histomorphometry. In fact, calcium supple-
mentation of Snx10 KD mice restored growth plate thickness (GpTh,) and osteoid volume
per bone volume (OV/BV, %) to values undistinguishable formWT (Fig. 5A, center and top
right and S6 Table). Bone volume / tissue volume (BV/TV, %), on the other hand, remained
significantly higher in the treated group compared to the WT (64.21 +/− 6.31% and 28.35 +/−
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Fig 5. Calcium supplementation can normalize calcium homeostasis and correct the rickets phenotype in Snx10 KDmice. Serum calcium (A, left),
GpTh (A, center) and OV/BV, (%;A, right) are normalized by calcium supplementation of Snx10 KDmice (Snx10 KD + Ca) (*, P<0.05, **, P<0.01). BV/TV
(%; A, bottom right) is not normalized by calcium supplementation. B) Radiographic images of femora and tibiae showmineralization of femoral condyles
(see inset) (C) Micro CT analysis of femora confirms partial re-mineralization of condyles and prevention of the “moth-eaten” cortical bone phenotype, as a
result of calcium supplementation in Snx10 KDmice.
doi:10.1371/journal.pgen.1005057.g005
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8.68%, respectively, P = 0.04, n = 3 per group, Fig. 5A, bottom right and S6 Table). We next an-
alyzed femora by micro-CT (Fig. 5C) and confirmed restoration of cortical bone in the calcium
supplementation group. Taken together, these results demonstrate that both the mortality and
the mineralization defect observed in Snx10 KD mice were caused by hypocalcaemia and were
prevented by calcium supplementation.
Osteoclast-specific Snx10 deficiency in vivo results in osteopetrosis with
no rickets
To determine the role of osteoclastic expression of Snx10 on bone homeostasis in vivo, we
used the recombination sites in the gene trap (S1A Fig.). Snx10 KD mice were crossed with
flippase-expressing mice to delete the selection cassette in exon 3, leaving a floxed allele that
deleted exons 4 and 5 of Snx10 specifically in osteoclasts when crossed with mice expressing
Cre under the control of the cathepsin K promoter (generously provided by Dr. Shigeaki Kato,
Institute of Molecular and Cellular Biosciences, The University of Tokyo). Exons 4 and 5
encode the PX domain, which is essential for phospholipid binding. We designated this allele
Snx10OC-. Snx10OC-/OC- homozygous animals are hereafter referred to as “Snx10 OC KO”, for
osteoclast knockout.
Snx10 OC KOmice showed a 95% reduction in Snx10 expression in bone (Fig. 6A); howev-
er expression in the stomach was not affected (Fig. 6B). Snx10 OC KOmice were viable and
had survival times that did not differ from their WT littermates. However, by 3 weeks of age
homozygotes exhibited mild growth retardation (Fig. 6C) with failure of tooth eruption
(Fig. 6E and 6G versus 6D and 6F). Radiograph analysis showed higher radio-density but no
metaphyseal plate widening, fraying or cupping of the tibia and femur, compared with the WT
(Fig. 6H-M). DXA analysis of 9 week-old bones revealed a significant 30% increase in Snx10
OC KOmice compared to WT (n = 8, 0.074 g/cm2 vs. 0.057 g/cm2, P = 0.0001). Micro-CT
analysis demonstrated the presence of cortical bone in the femur, and the skull surface was also
mineralized. Consequently, there was no "moth-eaten" appearance (Fig. 7A, top and bottom).
Similar to the Snx10 KD, the long bones of the Snx10 OC KOmice have marrow cavities filled
with unresorbed bone (Fig. 7A, center and 7C). Therefore, osteoclast-specific Snx10 deficiency
resulted in osteopetrosis.
Gastric pH was normal (3.06 +/− 0.3) and so was serum calcium (11.00 +/− 1.29 mg/dl for
the Snx10 OC KOmice vs. 11.89 +/− 1.33 mg/dl for the WT, Fig. 7B, left panel) and PTH
(0.176 +/− 0.012 ng/ml for the Snx10 OC KOmice vs. 0.142 +/−0.023 ng/ml for the WT,
Fig. 7B, right panel). Hematoxylin/eosin and Von Kossa/van Gieson staining of undecalcified
femur sections from Snx10 OC KOmice confirmed the presence of mineralized trabeculae
within the bone marrow space (Fig. 7C, top center panel). However, unlike the Snx10 KD mice,
the trabeculae were thoroughly mineralized and not covered by thick layers of unmineralized
osteoid (Fig. 7C, FEMUR center panel). The growth plate thickness (GpTh, mm) was signifi-
cantly larger than the WT (0.160 +/− 0.038 mm and 0.092+/− 0.002 mm, P = 0.03, n = 3 per
group, S3 Table) and so was the bone volume / tissue volume (BV/TV, %). The osteoid volume
per bone volume (OV/BV, %), on the other hand, did not vary significantly between WT and
Snx10 OC KOmice confirming that Snx10 OC KOmice are osteopetrotic but not rachitic
(S3 Fig.). Histomorphometry performed on sections from lumbar vertebral bodies (Fig. 7C,
VERTEBRA panel and S4 Table) and from skull base/floor bones (Fig. 7C, SKULL panel and
S5 Table) show similar results.
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Fig 6. Snx10 OC KOmice are osteopetrotic: Expression, morphological and radiographic analysis. A)
qPCR analysis of RNA from femur shows a 95% reduction in Snx10 expression in bones from Snx10 OC KO
mice. B) Snx10 expression in the stomach is not affected. C) 3-week-old Snx10 OC KOmice (right) are
growth retarded. E and G) 3-week-old Snx10 OC KOmice have a tooth eruption defect compared to their WT
littermates (D and F). Radiographs (I and L) show that 3-week-old Snx10 OC KOmice have bones without
marrow spaces and with a higher radio-density thanWT counterparts (H and K) or Snx10 KD (J and M). The
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Snx10-deficient osteoclasts have impaired extracellular acidification
capacity
We cultured osteoclast precursors fromWT and Snx10 KD mice on dentine slices with M-CSF
and RANKL to induce osteoclast differentiation and incubated them with the pH indicator
dye, acridine orange. Confocal microscopy revealed the presence of orange fluorescence (i.e.
low pH) in WT osteoclasts (Fig. 8A). Orange label was either absent or very faint in Snx10 KD
osteoclasts, indicating decreased acidification capacity (Fig. 8B).
Snx10-deficient osteoclasts have impaired endocytosis and form
rudimentary ruffled borders
The endocytic vesicles that contribute to the formation and maintenance of the ruffled border
originate in the basolateral membrane of the osteoclast [1]. To study the effect of Snx10 defi-
ciency on endosomal trafficking/vesicle formation and resorption, we performed dextran inter-
nalization assays and assessed resorption capacity on HA coated plates. WT cells internalized
dextran normally (green punctuate pattern, Fig. 8C). Snx10 KD cells, on the other hand, did
not (Fig. 8D). Ultrastructural examination of bone sections (we examined 8 bone sections—4
sections for WT and 4 sections for Snx10 KD—and observed 3 osteoclasts per section) by TEM
demonstrated a well-developed ruffled border in WT osteoclasts (Fig. 8E, black arrowheads)
whereas a rudimentary ruffled border was observed in Snx10-deficent osteoclasts (Fig. 8F).
Thus, Snx10 deficiency prevented endocytosis, severely impaired ruffled border formation, and
blocked resorption of HA.
Discussion
In this study we report that global Snx10-deficient mice (Snx10 KD) die at 3 weeks post-par-
tum and exhibit severe osteopetrosis with a superimposed mineralization defect. Snx10 KD os-
teoclasts fail to endocytose dextran, form a ruffled border, or acidify the resorption lacuna.
Despite these defects, CTX levels are greater in the Snx10 KD deficient mice. This is a seeming-
ly paradoxical result, given that Snx10 deficient-osteoclasts have a severe bone resorption
deficiency. However, similar results have been reported for severely osteopetrotic mice with de-
letions in the osteoclastic anion exchanger 2 (Ae2) [28], and with loss-of-function mutations in
the chloride channel 7 (clc-7) [34] and in cathepsin K [30]. This phenomenon may reflect the
fact that in osteoclast-rich osteopetrosis, as in these examples, there is a very large increase in
bone mass and bone surface area, resulting in a corresponding increase in the total number of
osteoclasts. One study of clc-7 KO mice [34] demonstrated that CTX per individual osteoclast
was reduced by 50% compared to the WT, but because there also was an increase in the total
number of osteoclasts, the total serum CTX was increased.
We also observed a mineralization defect in the Snx10 KDmice, consistent with rickets, sug-
gesting that Snx10 is also required for calcium homeostasis. Pursuing this, we found Snx10 to
be expressed in gastric zymogenic cells. Similar to osteoclasts, Snx10 KD zymogenic cells exhib-
it a defect in secretory vesicle formation/maintenance, leading to hypochlorhydria and hypo-
calcemia. The Snx10 KD mice thus exhibit a phenotype that is a combination of osteopetrosis
(due to impaired osteoclast resorption) and rickets (impaired mineralization due to poor calci-
um absorption). This is borne out by the correction of the rachitic phenotype when Snx10 is
knocked out specifically in osteoclasts, with normalization of stomach pH, circulating calcium,
metaphyseal fraying and cupping seen in the Snx10 KD femur and tibia are not observed in the Snx10 OC
KOmice (I and L), consistent with osteopetrosis with no rickets.
doi:10.1371/journal.pgen.1005057.g006
Control of Bone and Calcium Homeostasis by Snx10
PLOS Genetics | DOI:10.1371/journal.pgen.1005057 March 26, 2015 14 / 25
Fig 7. Histology andMicro CT analysis of Snx10 OC KOmice. A) Surface images of the femur (top), longitudinal mid-plane sections (middle) and skull
images (bottom) show that osteoclast-specific Snx10 deficiency leads to severely osteopetrotic bone, but unlike the global deficiency it does not result in a
lack of cortical bone. The white line in the longitudinal mid-plane sections (A, middle) indicates the location of the transverse micro-CT images were taken.
The transverse images show that, in contrast to the Snx10 KDmouse, Snx10 OC KOmice have cortical bone. B) Snx10 OC KOmice are normo-calcemic,
suggesting that that osteoclast-specific Snx10 deficiency does not have a major impact in calcium homeostasis. C) (top panel) H&E staining of longitudinal
sections of the proximal femur show abundant unresorbed cartilage in Snx10 OC KO and Snx10 KDmice, typical of osteopetrosis. The growth plate (GP) is
thicker in Snx10 KDmice. C) (FEMUR) Von Kossa/van Gieson staining of femur transverse sections close to the growth plate (cut at the depth of the white
line shown in the upper panels) show numerous trabeculae in both Snx10 OC KO and Snx10 KD tibiae, confirming the osteopetrotic phenotype. However,
while the trabeculae of Snx10 KDmice are not fully mineralized as evidenced by the pink-stained osteoid (right panels), the trabeculae of osteoclast-specific
Snx10 KOmice are fully mineralized (bottom panels). Similar results were observed for vertebra (C. VERTEBRA panel) and bones of the skull base/floor (C.
SKULL panel)
doi:10.1371/journal.pgen.1005057.g007
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and bone mineralization. Our results are in line with those of Schinke et al. [11] who analyzed
the combined acid defect phenotype by using mutations in different genes (Cckbr for the stom-
ach and Src for the osteoclasts). Similarly, the Tcirg1-deficient oc/ocmice have an osteopetror-
ickets phenotype due to impaired acidification in both stomach and bone [11]. These
observations unify the complex phenotype seen in Snx10 KD mice and osteopetrorickets pa-
tients as being due to the simultaneous inhibition of osteoclast function and gastric acid pro-
duction. Shinke et al [11] reported that 21 patients with diagnosed osteopetrosis had not been
genotyped and 10 of these patients had histological evidence of osteopetrorickets that had not
been diagnosed. Because calcium supplementation rescued mice from the rachitic phenotype
and dramatically extended life-span in Snx10 KD mice, our findings suggest that this may be a
critical component of the clinical approach to Snx10-dependent human osteopetrorickets.
Fig 8. Snx10-deficient osteoclasts are unable to acidify have impaired endosomal pathways, and
have defective ruffled borders. Acridine orange indicates acidification by osteoclasts derived fromWT
splenocytes (A), whereas none is present in Snx10 KD osteoclasts (B)(Nuclei labeled green). (C) WT
osteoclasts can internalize fluorescent dextran (green) but Snx10 KD osteoclasts (D) cannot. E) TEM images
of bone sections show a well-developed ruffled border in WT osteoclasts (black arrowheads). F) Snx10-
deficent osteoclasts form a severely defective ruffled border. BM: bone matrix. (HV = 80.0 kV).
doi:10.1371/journal.pgen.1005057.g008
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Because calcium gluconate is taken up at higher pH than calcium carbonte, it is the form
of choice.
There is a complex system of cross-regulation that exists between bone and most other or-
gans [35]. Our studies provide further evidence that there are instances of shared molecular
machinery for the production of acid in the stomach and in osteoclasts. TreeFam, a database of
phylogenetic trees from animal genomes that can be used to infer the evolutionary history of
genes, shows that Snx10 appears first in Osteichthyes, the bony fishes (http://www.treefam.org/
family/TF332117). The acid-secreting stomach also evolved in bony fishes. This raises the in-
triguing prospect that the osteoclastic and gastric acid producing systems evolved simulta-
neously during vertebrate evolution, together with emergence of a mineralized skeleton,
utilizing some of the same genes.
Snx10 appears to mediate both bone resorption and stomach acidification by regulating ve-
sicular trafficking. Our data and several other reports support a concordance between the se-
cretory trafficking mechanisms in OCs and zymogenic cells. For example, GNPTAB [36–38],
the enzyme required for adding mannose-6-phosphate to lysosomal hydrolases, when knocked
out in mice, causes defective OC and zymogenic cell trafficking. Gnptab-null mice also have
low BMD [38,39]. In the stomach, trafficking of digestive enzymes like PGC and acid secretion
(and, thus, calcium homeostasis) are linked. Loss of parietal cell acid secretion and/or damage
to parietal cells causes loss of mature zymogenic cells [31,40]. It is well-known that the fate and
function of parietal and zymogenic cells are profoundly intertwined [41]. Further studies may
reveal whether there is Snx10 expression in parietal cells, which may be too low to be seen in
the assays used here or if their function depends indirectly on Snx10 expression in zymogenic
cells.
Gastric acidification is essential for calcium absorption, and this regulatory pathway may be
disrupted in a variety of clinical conditions associated with hypochlorhydria ranging from
osteopetrorickets to antacid therapy. Proton-pump inhibitors, which block gastric acid produc-
tion and increase gastric pH, have recently been associated with hip fracture risk [42,43]. It has
been speculated that hypochlorhydria results in impaired calcium absorption thereby increas-
ing fracture risk. Similarly, endosteal bone resorption has been reported following gastric by-
pass surgery in rodents and humans [44,45]. The marked hyperparathyoirism of the Snx10 KD
mice was corrected in the Snx10 OC KOmodel, consistent with the hypocalcemia in the former
which was prevented by normal gastric acdification in the latter. Thus, our findings underscore
the relationship between gastric acidification and calcium absorption and its impact on bone
health in the general population (for an authoritative review on the topic see [46]), and
provide novel insights into the mechanisms governing the regulation of bone accrual via the
gastrointestinal tract.
Materials and Methods
Targeting vector and mouse models
All animal procedures were approved by IACUC of The Forsyth Institute. We obtained the
Snx10 targeting vector, PG00216_Z_2_C06, from the European Conditional Mouse Mutagene-
sis Program (EUCOMM). This vector is a “knockout first” gene trap (see S1A Fig.) which in-
serts a flippase site-flanked Neo selection cassette with an IRES and LacZ reporter into intron 3
and inserts LoxP sites flanking exons 4 and 5. Exons 4 and 5 contain the PX domain required
for phospholipid interactions, including all three phospholipid contact amino acid sequences.
This allele is designated Snx10tm1a(EUCOMM)Hmgu. Hereafter in this report, we refer to the result-
ing targeted allele as Snx10Neo-f. Mice homozygous for this allele are severely deficient in Snx10
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globally (see Results), so we hereafter refer to Snx10Neo-f/Neo-f mice as “Snx10 KD,” for Snx10
knockdown.
The gene-trap vector was electroporated into V6.5 ES cells. Neomycin resistant clones were
picked, expanded and screened for correct insertion by Long Range Genomic PCR using the
following vector-specific primers and gene-specific primers:
5' Integration
Gene Specific Forward (GF3). 5'-GCTTATGGTCGACTCATCGGAGAATC-3'
LacZ Reverse (LAR7), 5'-GGTGTGGGAAAGGGTTCGAAGTTCCTAT-3'
Amplicon size = 5,170 bp
3' Integration
LacZ Forward (LAF), 5'-GAGATGGCGCAACGCAATTAATG-3'
Gene Specific Reverse (GR4),5'-CACAGAAGTAATGTACGCTAATGGCAACG-3'
Amplicon size = 5,680 bp
The resulting clones were injected into host blastocysts to generate mouse chimeras. Two
male chimeras were bred with C57BL/6J females. Germ line transmission was confirmed by
PCR, using primers flanking the third loxP site (LoxP3 Forward: 5’-ATAACTAACCCAGG-
CAAACA-3’ and LoxP3 Reverse: 5’-TTGTCAAGTGCGTGTGTCGT-3’; S1A Fig., red arrows).
Snx10Neo-f/+ offspring were bred to homozygosity to generate animals for experiments at the
expected Mendelian ratio of approximately 25%. PCR genotyping using the preceding primer
pair produced bands of 213 bp for the WT (+/+), 273 bp for the Snx10Neo-f/Neo-f, and both
bands for the heterozygotes (S1B Fig.). For qPCR amplification of cDNA we used the following
primers (S1A Fig., black arrows): SNX10 (Forward): 5’-GAACAATCGCCAGCATGTCGAC-
3’ and SNX10 (Reverse): 5’-ATGTCC TCGGAGTTCAGATGGC-3’.
Osteoclast-specific Snx10-deficient mice were generated in two steps. First, the Neo cassette
was removed by crossing Snx10Neo-f/+ females with males homozygous for Rosa26-driven FLP
recombinase (strain B6.129S4-Gt(ROSA)26Sortm1(FLP1)Dym/RainJ) [47], resulting in an allele
with exons 4 and 5 flanked by loxP sites (Snx10f). Snx10f/f animals were viable and fertile.
Then, heterozygous males were crossed with females homozygous for Cre recombinase driven
by the cathepsin K promoter (Ctsk-Cre) [48]. The resulting mice carry an osteoclast-specific
Snx10 allele with exons 4 and 5 deleted, and therefore a null allele, which we designate
Snx10OC-. Snx10OC-/OC- homozygous animals are hereafter referred to as “Snx10 OC KO”, for
osteoclast knockout.
Radiographs and MicroCT
Radiographs were obtained with a Faxitron cabinet radiograph system (Model 43855A, Hew-
lett Packard, McMinnville, Oregon) with Kodak high-speed holographic film at 40 kV. For
micro-CT, mice were sacrificed by CO2 asphyxiation. Left femora, tibiae, mandibles and cal-
variae were then dissected and fixed in 4% paraformaldehyde (PFA, pH = 7.4) at 4°C for 18
hours, followed by 70% ethanol, then stored at 4°C until scanned. Samples were scanned (μCT
40, Scanco Medical) for 3D reconstruction and the following parameters were estimated: BV/
TV (bone volume per tissue volume), Tb.N (trabecular number), Tb.Th. (trabecular thickness),
Tb.Sp (trabecular spacing), and bone mineral density (BMD). Micro-CT slices, each with a
slice thickness reconstructed to 10 μm (100 slices/mm), were obtained delivering a 3-dimen-
sional representation of approximately 3 mm of anatomy. The imaging was done at 55kV,
145μA.
Mechanical testing. Previous to the mechanical test, the proximal femur was immersed in
acrylic resin until solidification. A loading force was applied to the femoral head using a
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concave loading cup at a constant speed of 0.155 mm/s until failure. The following parameters
were analyzed: maximal load, stiffness, work to failure and maximal displacement. Maximal
load reflects the general integrity of the bone structure; stiffness is closely related to the miner-
alization of the bone; energy to failure is the amount of energy necessary to break the bone; and
maximal displacement is inversely related to the brittleness of the bone [25].
Isolation of spleen cells and osteoclast differentiation
We used splenocytes as the source of osteoclast precursors because long bones in osteopetrotic
mice lack marrow cavities. Spleens were resected from 4 week-old mutant and WTmice and
mashed through a cell strainer (BD Falcon, Mesh Size: 40μm) To induce osteoclast differentia-
tion, splenocytes were plated in a 24-well plates (1 x 106 cells/well) in alpha-MEM/10% FBS
supplemented with M-CSF (25 ng/ml) and RANKL (50 ng/ml)(both from Peprotech). Cells
were cultured for 7 days with changes of medium and cytokines every other day.
Lentivirus construction. A 605-bp human Snx10 cDNA, containing the entire ORF, was
amplified by RT-PCR from RNA from osteoclasts derived from human peripheral blood
mononuclear cells (PBMC) using the following primers:
Sense: 50-GATATGTTTCCGGAACAACAGAAAG-30
Antisense: 50-TCAGGATTCCTGCGGAGCTGTATTT-30
The cDNA was then sub-cloned into the expression vector pLenti6.3/V5-TOPO (Life Tech-
nologies Corporation) and was used to generate lentiviral particles using the ViraPower HiPer-
form Lentiviral TOPO Expression Kit (Invitrogen) according to the
manufacturer’s instructions.
Lentiviral infection
Spleen cells were cultured overnight in alpha-DMEM/10% FBS supplemented with 50ng/ml
M-CSF in 24-well plates (1 x 106 cells/well). The next day, the medium was removed and the
cells were incubated overnight with lentiviral particle-containing medium in the presence of
polybrene (6ug/ml). The following day, the culture medium was replaced with fresh medium
containing M-CSF and RANKL. The cells were cultured under osteoclast differentiation condi-
tions for 7 days, with changes of medium and cytokines every other day.
Pit formation assay
Spleen cells were plated (1 x 106 cells/well) on 24-well Osteo Assay Surface plates (Corning) in
alpha-MEM supplemented with 50ng/ml M-CSF. The following day cells were infected with
Snx10 lentiviral particles and 24 hours later the medium was replaced with fresh medium con-
taining M-CSF and RANKL. The cells were cultured under osteoclast differentiation conditions
for 7 days as above. Cells were then removed by incubation with 10% bleach solution. The
wells were washed with PBS, air-dried and photographed under a light microscope. The area of
resorption pits was quantified using Image J (National Institutes of Health, Bethesda, MD).
Dextran internalization
Osteoclast precursors were cultured on bovine dentine slices in alpha-MEM supplemented
with M-CSF and RANKL to induce osteoclast differentiation. Differentiated osteoclasts were
incubated with 200 μg/ml aldehyde fixable Alexa 488-dextran (Life Technologies, Grand Is-
land, NY, USA) overnight at 37°C. Cultures were fixed in 4% PFA for 15 minutes, counter-
stained with DAPI (4,6-diamidino-2-phenylindole) to visualize nuclei, and mounted on
glass cover slips for fluorescence microscopy. Digital images (obtained using fluorescence
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microscope FSX100, Olympus) were processed with Image J to obtain an interactive 3D surface
plot, where the height of the surface plot reflects image brightness, corresponding to the
amount of internalized dextran. Multinucleated cells were counted and each cell was assessed
for dextran endocytosis.
Extracellular acidification
Osteoclasts cultured on dentine slices as above were incubated with 5ug/ml acridine orange
(Sigma) for 15 minutes at 37°C, rinsed with PBS and chased for an additional 15 minutes. Im-
ages were obtained using a Leica SP5X Laser Scanning Confocal Microscope with a 490-nm ex-
citation filter and a 525-nm emission filter. Digital images were processed with Image J.
Multinucleated cells were counted and assessed for the presence of extracellular acidification.
Experiments were performed in triplicate and the results were expressed as the proportion of
acidification-positive osteoclasts in the total number of osteoclasts (±sd). Differences were ana-
lyzed using Student’s t-test and considered significant if P<0.05.
TRAP staining
After culturing cells for 7 days in the presence of RANKL and M-CSF, cultures were washed
with PBS, fixed first in 4% PFA for 5 minutes, then briefly in ethanol/acetone, 50%/50%, and
air dried for 2 minutes. Cells were then incubated in tartrate resistant acid phosphatase
(TRAP) staining solution (Napthol AS-MX phosphate and Fast Red Violet LB Salt) at 37°C
until the color developed (10 minutes to 1 hour). The wells were then washed with PBS, air-
dried and photographed under a light microscope.
Histology
Mouse femora were fixed in 4% PFA overnight at 4°C and stored in 50% alcohol at room tem-
perature. For paraffin embedding, the specimens were washed with 5, 10, and 15% glycerol in
PBS, each for 15 min and decalcified with 10% EDTA in 0.1M TRIS for 2 weeks. Specimens
were then embedded in low melting temperature paraffin and sectioned at 5-μm intervals. De-
calcified paraffin sections were used for H&E, IHC and TRAP staining. For plastic embedding,
the specimens were dehydrated in a graded series of alcohols then infiltrated and embedded in
a methyl and butyl methacrylate resin. Each femur was bisected longitudinally with a precision
saw and cross-sections (transverse) were cut at the mid-diaphysis (plane 1) and longitudinal
planes in the proximal-to-distal orientation (plane 2). Plane 1 and 2 segments were sectioned
using a Leica RM2165 microtome and collected onto coated slides, press-mounted and dried in
an oven set at 50°C for several hours. Slides were deplasticized in xylenes, rehydrated in a grad-
ed alcohol series into deionized water, stained with Von Kossa-Van Gieson’s stains [11], and
covered with a cover slip. Micro-ground sections were prepared from planes 1 and 2 sawed seg-
ments, mounted onto plastic slides, then ground and polished to a thickness of<80 microns
using the EXAKT CS400 system (EXACT Technologies, Oklahoma City, OK). The micro-
ground slides were etched in a solution of 50% acetone + 50% dehydrated ethanol, rinsed in de-
ionized water, then stained with Von Kossa-Van Gieson’s stain, and covered with a cover slip.
Freshly obtained stomach samples were fixed overnight in 4% formalin at 4°C, rinsed in
70% ethanol, arranged in 2% agar in a tissue cassette, and paraffin embedded. 5μm sections
were cut, paraffin was removed, and the sections were rehydrated. Antigen retrieval was done
for 20 minutes in boiling Trilogy solution (Cell Marque, Rocklin, CA), blocked for 1 hour in
1% bovine serum albumin, 0.3% Triton X-100 in PBS and incubated with primary antibodies
overnight. Primary antibodies used were Snx10 (Santa Cruz SC-104657, 1:200), VEGF-B
(Santa Cruz SC-1876, 1:250), and GIF (a gift from Dr. David Alpers, Washington University
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School of Medicine, 1:2000). Secondary antibodies, GSII lectin and Hoechst 33358 labeling
were as described [32]
Morphometric methodology
Using morphometric software (i.e., Olympus MicroSuite Biological Suite or cellSens), five high
magnification images of methylmethacrylate sections were acquired from the sub-articular re-
gion (i.e., immediately subjacent to the growth plate) of the proximal femur (40x), the bones of
the skull base/floor (i.e., basisphenoid) (40x) and lumbar vertebral bodies (20x). Calibrated im-
ages of the femora, calvariae, and vertebrae were then morphometrically assessed to determine:
osteoid volume/bone volume (OV/BV, %) and bone volume/tissue volume (BV/TV, %), and,
in addition, the growth plate thickness (GpTh, mm) of distal femur, all as described [49]. Bone
and osteoid volume were calculated based on the summation of all five sampling fields. Ratios
(i.e., OV/BV and BV/TV) are presented as the average of all five fields. Since our morphometry
was done in 2D we measured areas and then calculated volumes (i.e., by multiplying perimeter
area values 4/π to getsurface/volume). Data were consolidated and presented as mean ± sd
Transmission electron microscopy
Mice were perfused with 4% (w/v) PFA and 1% (v/v) glutaraldehyde in 0.1 M phosphate buffer
(pH 7.4). Femora were isolated, defleshed and immediately fixed in 4% (w/v) PFA and 1%
(v/v) glutaraldehyde in 0.1 M phosphate buffer (pH 7.4) at 4°C for 1 h prior to cutting the
femur into approximately 1 mm slices, which continued to be fixed for additional 24 h and
then rinsed in 0.1M sodium phosphate buffer. Bone slices were decalcified in 10% (w/v) EDTA
in PBS for 3 days, post fixed in 1% (v/v) OsO4 and embedded in Epon-812 resin (Tousimis,
Rockville, MD). Ultrathin sections (n = 4 per group) were then made and stained with uranyl
acetate and lead citrate, and examined with a FEI Tecnai G2 Spirit Transmission Electron
Microscope.
Measurement of gastric pH
Gastric pH was measured as described [50]. Briefly, mice were fasted for 2 hours prior to the
test and anesthetized. The stomach was then exposed after abdominal midline incision, fol-
lowed by ligation of the pylorus and esophagus. Saline solution was then injected into the stom-
ach and the fluids collected. The pH of the collected fluid was measured using a Star A321 pH
Meter (Thermo Scientific Orion) equipped with a PerpHecT ROSS pH electrode with micro
tip (Thermo Scientific Orion).
Determination of serum calcium, PTH and 1,25- dihydroxyvitamin D3
For analysis of calcium homeostasis, blood was obtained by cardiac puncture and collected in
heparinized Eppendorf tubes. Serum was isolated by centrifugation at 3000 g for 10 min and
stored at −80°C. Serum calcium was measured by the Clinical & Epidemiologic Research Labo-
ratory at Children’s Hospital (Boston, MA), a nationally certified laboratory, using a colorimet-
ric assay on a Hitachi 917 analyzer using Roche reagents (Roche Diagnostics, Indianapolis,
IN). The lowest detection limit of this assay is 0.2 mg/dL and the day-to-day imprecision values
at concentrations of 8.38, 9.12 and 13.13 mg/dL are 1.5%, 1.6%, and 0.8%, respectively. PTH
was determined using the Mouse PTH 1–84 ELISA Kit (Cat.# 60-2305, Immutopics, Inc., San
Clemente, CA). 1,25- dihydroxyvitamin D was determined using the Mouse Vitamin D, VD
ELISA Kit (CSB-E07912m, Cusabio Life Science).
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Determination of markers of bone formation and resorption
Quantification of fragments of type I collagen in serum was done using the RatLap EIA kit
from IDS (Immunodiagnostic Systems, AC-06F1) following the manufacturer's instructions.
Serum osteocalcin was measured using the Mouse Osteocalcin ELISA Kit from Immutopics
(60-1305), following the manufacturer's instructions.
Supporting Information
S1 Fig. Generation of Snx10 KD mice. A) Vector PG00216_Z_2_C06. Insertion of this vector
into the Snx10 locus by homologous recombination produces an allele of the type: “Knockout-
First—Reporter Tagged Insertion” (Promoter Driven Cassette). B) PCR genotyping of Snx10+/+
(WT), Snx10 Neo-f/+, and Snx10Neo-f/Neo-f (Snx10 KD) mice. C) Snx10 KD mice are Snx10-defi-
cient. Snx10 expression in bone is reduced by*86% in Snx10 KD mice (relative expression
Snx10 KD = 0.14 vs. WT = 1.03, n = 4 per group, P<0.05).
(TIF)
S2 Fig. Snx10 deficiency inhibits osteoclast formation and activity in vivo and in vitro. A)
TRAP staining (red) of longitudinal tibia sections from Snx10 KD mice show that Snx10 KD
mice have osteoclasts (magnification 10X). Splenocytes fromWT (B) or Snx10 KD (C) mice
can generate TRAP+ osteoclasts after ex vivo stimulation. D) Osteoclasts derived fromWT, but
not from Snx10 KD splenocytes, can resorb hydroxyapatite (top and middle panel). Infection
of Snx10 KD splenocytes with a virus expressing Snx10 (Snx10 KD + Snx10), corrects the de-
fective resorption phenotype ( P< 0.05)
(TIF)
S3 Fig. Snx10 KD and Atp6i KO mice show a combined phenotype: osteopetrorickets. A) Ra-
diographs (top and bottom panels) show that Snx10 KD and Atp6i KO mice have bones with a
higher radio-density and lack cortical bone. The metaphyseal fraying and cupping seen in the
femur and tibia are features of rickets (bottom panels). B) Micro-CT surface images of the
femur show cortical bone deficiency, which produces a “moth-eaten” appearance and also con-
firms hypo-mineralization of condyles in both mutants. The white line in the longitudinal
mid-plane sections (B, top) indicates the region where the transverse micro-CT images were
taken (B, bottom).
(TIF)
S4 Fig. Snx10 KD mice displayed reduced zymogenic cell granular size and abundance. A) IF
images from stomach sections fromWT and Snx10 KD mice stained for GIF (a zymogenic cell
marker, ZC), Snx10, GSII (a marker for the mucous neck cells interspersed with the parietal
cells in the neck of the gastric unit) shows Snx10-specific staining in WT zymogenic cells. B)
H&E confirms the small size and high nuclear:cytoplasmic ratio of parietal cells in KO gastric
units (also noted in Fig. 5D). The ZCs, lacking their abundant apical granules, are also smaller,
and there are increased parietal cells in the base (ZC) zone (black arrowheads). This zymogenic
defect phenotype resembles theMist1 KOmouse.
(TIF)
S1 Table.Mechanical properties of diaphyseal tibiae fromWT and Snx10 KD mice.
(DOCX)
S2 Table. FEMUR histomorphometry: WT and Snx10 KD (3.5 week-old mice).
(DOCX)
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S3 Table. FEMUR histomorphometry: WT and Snx10 OC KO (6 week-old mice).
(DOCX)
S4 Table. VERTEBRA histomorphometry: WT, Snx10 OC KO and Snx10 KD (6 week-old
mice).
(DOCX)
S5 Table. SKULL histomorphometry: WT, Snx10 OC KO and Snx10 KD (6 week-old mice).
(DOCX)
S6 Table. FEMUR histomorphometry: Calcium supplementation of Snx10 KD mice (111 day
old mice, Femur).
(DOCX)
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